---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-003691"
form_type: "8-K"
ticker: "SXTP"
cik: "0001946563"
company_name: "60 DEGREES PHARMACEUTICALS, INC."
filed_at: "2024-01-16T23:59:59+00:00"
generated_at: "2026-06-06T23:31:03.825671+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# 60 Degrees Pharmaceuticals regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq letter on Jan 10, 2024 confirming compliance with Bid Price Rule 5550(a)(2).
- Closing bid price averaged $1.00 or more for 10 consecutive business days through Jan 9, 2024.
- Previously received deficiency notice on Nov 2, 2023; delisting risk now resolved.
- Company's common stock (SXTP) and warrants (SXTPW) continue trading on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001213900-24-003691
- form_type: 8-K
- ticker: SXTP
- cik: 0001946563
- company_name: 60 DEGREES PHARMACEUTICALS, INC.
- filed_at: 2024-01-16T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1946563/000121390024003691/0001213900-24-003691-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1946563/000121390024003691/ea191500-8k_60degrees.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-003691
- JSON: https://secwatch.observer/filing/0001213900-24-003691.json
- Plain text: https://secwatch.observer/filing/0001213900-24-003691.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.